Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Hanenberg

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Plos One|June 6, 2014
Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and developmentTimothy W Corson, Brian C Samuels, Andrea A Wenzel, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2007
Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiationEllen Fritsche, Claudia Schäfer, Christian Calles, et al.
Plos One|January 5, 2011
Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cellsAntonio Valeri, Maria Eugenia Alonso-Ferrero, Paula Río, et al.
Stem Cells (Dayton, Ohio)|February 13, 2014
Human adipose-derived stromal/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectorsTatsuyoshi M Kono, Emily K Sims, Dan R Moss, et al.
Nature Genetics|August 24, 2005
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemiaOrna Levran, Claire Attwooll, Rashida T Henry, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2010
The centrosome and mitotic spindle apparatus in cancer and senescenceStephen Schmidt, Frank Essmann, Ion C Cirstea, et al.
Oncoimmunology|February 16, 2017
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-GSareetha Kailayangiri, Bianca Altvater, Christian Spurny, et al.
Frontiers in Immunology|April 25, 2022
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological MalignanciesMaren Soldierer, Arthur Bister, Corinna Haist, et al.
Journal of the National Cancer Institute|October 16, 2003
Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemiaKenneth Offit, Orna Levran, Brian Mullaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck CancersAnne J Lombardi, Elizabeth E Hoskins, Grant D Foglesong, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Plos One|June 6, 2014
Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and developmentTimothy W Corson, Brian C Samuels, Andrea A Wenzel, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2007
Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiationEllen Fritsche, Claudia Schäfer, Christian Calles, et al.
Plos One|January 5, 2011
Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cellsAntonio Valeri, Maria Eugenia Alonso-Ferrero, Paula Río, et al.
Stem Cells (Dayton, Ohio)|February 13, 2014
Human adipose-derived stromal/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectorsTatsuyoshi M Kono, Emily K Sims, Dan R Moss, et al.
Nature Genetics|August 24, 2005
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemiaOrna Levran, Claire Attwooll, Rashida T Henry, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2010
The centrosome and mitotic spindle apparatus in cancer and senescenceStephen Schmidt, Frank Essmann, Ion C Cirstea, et al.
Oncoimmunology|February 16, 2017
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-GSareetha Kailayangiri, Bianca Altvater, Christian Spurny, et al.
Frontiers in Immunology|April 25, 2022
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological MalignanciesMaren Soldierer, Arthur Bister, Corinna Haist, et al.
Journal of the National Cancer Institute|October 16, 2003
Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemiaKenneth Offit, Orna Levran, Brian Mullaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck CancersAnne J Lombardi, Elizabeth E Hoskins, Grant D Foglesong, et al.
Pageof 16